What is the concentration percentage of diclofenac in regular Voltaren (diclofenac sodium) gel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Voltaren Gel Concentration

Regular Voltaren gel contains 3% diclofenac sodium in a 2.5% hyaluronic acid gel formulation. 1, 2

Standard Formulation Details

  • The licensed formulation is diclofenac 3% in 2.5% hyaluronic acid gel, approved for twice-daily application over 60-90 days for actinic keratosis treatment 1, 2

  • This 3% concentration should not be confused with other diclofenac topical products, which come in different strengths:

    • 1% diclofenac sodium gel (Voltaren Gel) for osteoarthritis 3
    • 2% diclofenac sodium topical solution for knee osteoarthritis 4
    • 1.16% diclofenac diethylamine emulsion (Voltaren Emulgel) 5, 6
    • 0.1% diclofenac sodium ophthalmic solution for eye conditions 7

Important Clinical Distinction

  • The concentration alone does not determine efficacy or absorption. A study comparing 1.16% diclofenac diethylamine emulsion versus 5% diclofenac sodium gel showed the lower-concentration product achieved 7-fold greater skin permeation (0.54% vs 0.077% of applied dose), demonstrating that formulation characteristics—including viscosity, composition, and drug solubility—matter more than concentration percentage 5

  • The 3% gel formulation in hyaluronic acid has lower viscosity (allowing better penetration) compared to higher-concentration gels that may have reduced bioavailability due to formulation properties 5

Regulatory Context

  • The 3% diclofenac gel is specifically licensed for adult patients with actinic keratosis only, not for pediatric populations or musculoskeletal indications 8, 2

  • All diclofenac formulations carry cardiovascular risk warnings, including increased risk of myocardial infarction and stroke, particularly in patients with cardiovascular disease or risk factors 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diclofenac Gel 3% for Actinic Keratosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[The percutaneous absorption of diclofenac].

Arzneimittel-Forschung, 1986

Guideline

Diclofenac Eye Drops: Formulations and Usage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diclofenac Gel Use in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.